We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Entegrion, Inc.

Entegrion is a life sciences company dedicated to providing innovative solutions to improve clinicians’ ability to ef... read more Featured Products: More products

Download Mobile App




Next Gen Viscoelastic Coagulation Monitor Enables Rapid Hemostasis Assessment at Patient Side

By LabMedica International staff writers
Posted on 31 May 2023
Print article
Image: VCM viscoelastic testing instrument provides rapid, real-time hemostasis assessment at POC (Photo courtesy of Entegrion)
Image: VCM viscoelastic testing instrument provides rapid, real-time hemostasis assessment at POC (Photo courtesy of Entegrion)

The use of viscoelastic coagulation testing is on the rise for various applications such as trauma, surgery, obstetrics, major disease management, and more. It provides crucial information not obtained from conventional coagulation tests. Now, a next-generation viscoelastic testing device has been introduced, enabling quick, real-time assessment of hemostasis at the point of care.

Entegrion, Inc.’s (Durham, NC, USA) viscoelastic coagulation monitor, VCM, is designed to serve as a truly efficient point-of-care solution. It represents a significant advancement over existing viscoelastic testing systems, featuring accessibility, user-friendly operation, and impressive portability. The VCM system requires a small amount of fresh, non-citrated whole blood, which is input directly into the device at the patient's side. The fully automated test eliminates the need for chemical accelerants and sample manipulation, thus saving crucial time and preserving the sample's original properties.

The VCM system includes an analyzer, disposable cartridges, and a heater plate used to heat the cartridges to 37°C during the pre-test phase. After drawing blood, a small unmetered sample is added to the cartridge via an extra cup. The precise amount of blood required automatically flows into the cartridge, filling the space between two glass surfaces. The extra cup is then removed, the lateral port is closed, and the cartridge is placed in the analyzer to commence the test. The analyzer maintains a constant internal temperature and humidity throughout the process.

With its compact size, the VCM has the potential for a wide range of applications in various clinical settings, including pre-hospital emergency medicine. The VCM system has secured regulatory approval in Europe and will be available in Europe and other regions that accept CE Marked products. However, the system has not yet been cleared for clinical use in humans in the United States.

Related Links:
Entegrion, Inc. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.